Musical Performance and Biomedical Human Enhancement: Ethnographic Perspectives on Bioethical Questions

This article explores the use of biomedical human enhancement in the field of musical performance, focusing on the role of beta-blocking drugs, which have been used by classical musicians since the 1970s to control the symptoms of performance anxiety, primarily in high-stakes auditions. Insights gained from in-depth, structured, ethnographic interviews with professional classical musicians suggest that, unlike professional athletic communities (in which the use of beta-blocking drugs to control performance anxiety is often banned), classical musicians often view the use of beta-blocking drugs as a legitimate form of therapy or as a training tool. Although dominant bioethical frameworks for understanding human enhancement focus on values of autonomy, hard work, fairness, and justice, these values were largely absent from the way musicians conceived of beta-blocker use in their community. At a time when the use of beta-blocking drugs to control performance anxiety is spreading to job interviews, examining the impact of beta-blocker use in the field of classical music offers a real-world case study that shows how cultural values within individual communities shape ethical questions involving biomedical human enhancements.

Authors

Publication Details

Journal
The Hastings Center Report
Published
2026-05-01
DOI
https://doi.org/10.1002/hast.70031
Primary Topic
Neuroethics, Human Enhancement, Biomedical Innovations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Musical Performance and Biomedical Human Enhancement: Ethnographic Perspectives on Bioethical Questions

Jennifer Saltzstein
The Hastings Center Report
Neuroethics, Human Enhancement, Biomedical Innovations
article

Musical Performance and Biomedical Human Enhancement: Ethnographic Perspectives on Bioethical Questions

Jennifer Saltzstein
article en

Abstract

This article explores the use of biomedical human enhancement in the field of musical performance, focusing on the role of beta-blocking drugs, which have been used by classical musicians since the 1970s to control the symptoms of performance anxiety, primarily in high-stakes auditions. Insights gained from in-depth, structured, ethnographic interviews with professional classical musicians suggest that, unlike professional athletic communities (in which the use of beta-blocking drugs to control performance anxiety is often banned), classical musicians often view the use of beta-blocking drugs as a legitimate form of therapy or as a training tool. Although dominant bioethical frameworks for understanding human enhancement focus on values of autonomy, hard work, fairness, and justice, these values were largely absent from the way musicians conceived of beta-blocker use in their community. At a time when the use of beta-blocking drugs to control performance anxiety is spreading to job interviews, examining the impact of beta-blocker use in the field of classical music offers a real-world case study that shows how cultural values within individual communities shape ethical questions involving biomedical human enhancements.

The Hastings Center ReportVol. 56(3)
Openalex Percentile: Top 10%
Neuroethics, Human Enhancement, Biomedical Innovations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Musical Performance and Biomedical Human Enhancement: Ethnographic Perspectives on Bioethical Questions — Jennifer Saltzstein · The Hastings Center Report (2026) | TGRS Research Map | TGRS